XML 34 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,703) $ (12,029)
Adjustments to reconcile net cash used in operating activities:    
Depreciation and amortization expense 11,412 12,227
Impairment charges 288  
Stock-based compensation 1,438 2,079
Allowance for doubtful accounts (274) 158
Common stock issued under defined contribution 401(k) plan 499 345
(Gain) loss on disposal of assets (3,576) 220
Changes in operating assets and liabilities:    
Accounts receivable (1,613) (3,318)
Inventories (10,637) (5,672)
Prepaid expenses and other current assets 1,228 1,078
Accounts payable 12,337 (3,175)
Accrued liabilities 1,054 (110)
Customer deposits 17,419 (13,411)
Other non-current assets and liabilities (365) 1,319
Net cash provided by (used in) operating activities 21,507 (20,289)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of logistics business and related note receivable 250 375
Purchases of available for sale securities (867)  
Purchases of property and equipment (5,967) (3,300)
Proceeds from disposals of property and equipment 12,533 106
(Increase) decrease in restricted cash (1) 546
Net cash provided by (used in) investing activities 5,948 (2,273)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on lines of credit and notes payable (80,233) (24,190)
Proceeds from lines of credit and notes payable 75,208 36,908
Proceeds from sale-leaseback transactions   1,000
Payments for debt issuance costs   (630)
Principal payments on capital leases (120) (1,145)
Net Cash Provided by (Used in) Financing Activities (5,145) 11,943
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 22,310 (10,619)
CASH AND CASH EQUIVALENTS, beginning of the period 516 13,340
CASH AND CASH EQUIVALENTS, end of the period 22,826 2,721
Supplemental cash flow information:    
Interest paid 672 854
Income taxes paid 19 25
Non-cash investing and financing activities:    
Issuance of restricted stock grants $ 1,025 $ 1,307